Thomas L. Rodgers, Executive Vice President, Chief Strategy and Business Development Officer, announced his intention to retire effective August 1, 2026. To facilitate a transition, Ramesh Srinivasan will be appointed as Executive Vice President, Chief Strategy Officer, also effective August 1, 2026. McKesson Corporation is a healthcare company providing pharmaceutical and medical supplies distribution.

On June 9, 2026, McKesson Medical-Surgical Top Holdings, Inc., a subsidiary of McKesson Corporation, entered into an amendment to its existing Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment establishes a $2,250.0 million senior secured term "B" loan facility due in 2032. Borrowings under this facility carry an interest rate at the Borrower's option of either the Adjusted Term SOFR Rate plus 2.25% per annum or the Base Rate plus 1.25% per annum. The facility is secured by substantially all tangible and intangible assets of the Borrower and its material U.S. subsidiaries. McKesson Corporation is a healthcare company providing pharmaceutical and medical-surgical distribution services.